私募股权公司与加拿大Weston家族洽谈90亿美元收购Boots

私募股权公司Sycamore Partners正与加拿大Weston家族就出售英国药房连锁店Boots进行高级谈判，交易金额达90亿美元（70亿英镑）1。该交易有望在一周内完成1，将标志着Weston家族重返英国高街零售业1。

Boots在英国拥有1800家门店，雇用约5.1万人1。根据最新财务数据，Boots截至2025年8月底的财政年度收入为75亿英镑，同比增长3.2%；税前利润达3.37亿英镑，增幅达25%1。

Weston家族在加拿大和全球零售业中拥有广泛业务，包括Loblaws超市、Shoppers Drug Mart药房和Primark多数股份1。Sycamore Partners于2025年以237亿美元收购Walgreens Boots Alliance，此次出售Boots是该交易的一部分1。值得注意的是，Sycamore曾在2025年夏季与澳大利亚制药集团Sigma Healthcare进行过100亿美元的并购谈判，但最终失败1。

Private equity firm Sycamore Partners is in advanced negotiations with Canada's Weston family to sell the British pharmacy chain Boots for $9 billion, according to reports 1. The transaction is expected to be finalized within a week, marking a significant return for the Weston family to British high street retail 1.

Boots operates approximately 1,800 stores across the United Kingdom and employs around 51,000 people 1. In the fiscal year ending August 2025, the chain generated revenue of 7.5 billion British pounds, representing a 3.2 percent increase year-over-year, while pre-tax profit rose 25 percent to 337 million British pounds 1. The Weston family, which already controls supermarket chain Loblaws, Shoppers Drug Mart pharmacy, and a majority stake in fashion retailer Primark, would expand its retail footprint with the acquisition 1.

Sycamore Partners acquired Boots as part of its $237 billion takeover of parent company Walgreens Boots Alliance in 2025 1. The proposed sale follows a failed attempt by Sycamore to merge Boots with Australian pharmaceutical group Sigma Healthcare in a $10 billion deal during the summer of 2025 1.